ERBB2 and breast carcinoma: Decoding the feedback mechanisms that breast cancer cells use to reverse the inhibited HER2 signaling is also critical for understanding the dynamic regulation of HER2 signaling network and would provide novel targets to overcome the resistance to HER2 inhibitors.